Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contribution of Anti-platelet Antibodies in Diagnosing Autoimmune Thrombocytopenia
NCT04800458Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2021
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Percentage of patients with a diagnosis of autoimmune thrombocytopenia among those with identified anti-platelet antibodies at 12 months. Started May 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04800458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800458.